Fortrea Holdings Inc. (FTRE)
FTRE Stock Price Chart
Explore Fortrea Holdings Inc. interactive price chart. Choose custom timeframes to analyze FTRE price movements and trends.
FTRE Company Profile
Discover essential business fundamentals and corporate details for Fortrea Holdings Inc. (FTRE) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
20 Jun 2023
Employees
15.00k
Website
https://www.fortrea.comCEO
Anshul Thakral
Description
Fortrea Holdings Inc. functions as a global contract research organization (CRO), concentrating on providing development services for biopharmaceutical products and medical devices. The company's operations are divided into two main segments: Clinical Services and Enabling Services. Its Clinical Services division offers support across the entire spectrum of clinical pharmacology and development. The Enabling Services segment, conversely, delivers patient access programs and cutting-edge clinical trial technology solutions, aiming to simplify complex randomization processes and optimize the supply of trial medications for its customers. Fortrea presents a range of engagement options, such as full-service provision, functional service provider (FSP) models, and hybrid structures. Additionally, its portfolio includes managing clinical trials from Phase I through IV, offering distinctive technology-powered trial solutions, and providing post-market approval services. The company's client base primarily consists of pharmaceutical, biotechnology, and medical device entities. Fortrea Holdings Inc. was founded in 2023 and has its headquarters in Durham, North Carolina.
FTRE Financial Timeline
Browse a chronological timeline of Fortrea Holdings Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 29 Jul 2026
EPS estimate is $0.18, while revenue estimate is $647.53m.
Earnings released on 5 May 2026
EPS came in at $0.16 surpassing the estimated $0.03 by +433.33%, while revenue for the quarter reached $636.50m , beating expectations by +1.27%.
Earnings released on 26 Feb 2026
EPS came in at $0.09 falling short of the estimated $0.16 by -43.75%, while revenue for the quarter reached $660.50m , missing expectations by -0.71%.
Earnings released on 5 Nov 2025
EPS came in at $0.12 falling short of the estimated $0.16 by -25.00%, while revenue for the quarter reached $701.30m , beating expectations by +5.42%.
Earnings released on 6 Aug 2025
EPS came in at $0.19 surpassing the estimated $0.06 by +216.67%, while revenue for the quarter reached $710.30m , beating expectations by +13.94%.
Earnings released on 12 May 2025
EPS came in at $0.02 surpassing the estimated -$0.07 by +128.57%, while revenue for the quarter reached $651.30m , beating expectations by +6.61%.
Earnings released on 3 Mar 2025
EPS came in at $0.18 falling short of the estimated $0.36 by -50.00%, while revenue for the quarter reached $697.00m , beating expectations by +5.45%.
Earnings released on 8 Nov 2024
EPS came in at $0.23 falling short of the estimated $0.27 by -14.81%, while revenue for the quarter reached $674.90m , missing expectations by -4.12%.
Earnings released on 12 Aug 2024
EPS came in at -$0.03 falling short of the estimated $0.07 by -142.86%, while revenue for the quarter reached $662.40m , missing expectations by -3.87%.
Earnings released on 13 May 2024
EPS came in at -$0.04 falling short of the estimated -$0.01 by -619.42%, while revenue for the quarter reached $662.10m , missing expectations by -12.26%.
Earnings released on 11 Mar 2024
EPS came in at $0.19 falling short of the estimated $0.23 by -17.39%, while revenue for the quarter reached $775.40m , missing expectations by -0.47%.
Earnings released on 13 Nov 2023
EPS came in at $0.24 surpassing the estimated $0.18 by +33.33%, while revenue for the quarter reached $776.40m , beating expectations by +3.67%.
Earnings released on 14 Aug 2023
EPS came in at $0.52 surpassing the estimated $0.39 by +33.33%, while revenue for the quarter reached $793.00m , beating expectations by +2.79%.
Earnings released on 31 Mar 2023
EPS came in at -$0.13 , while revenue for the quarter reached $764.20m .
Earnings released on 31 Dec 2022
EPS came in at $0.45 , while revenue for the quarter reached $3.10bn .
Earnings released on 30 Sept 2022
EPS came in at $0.69 , while revenue for the quarter reached $762.30m .
Earnings released on 29 Jun 2022
EPS came in at $0.75 , while revenue for the quarter reached $793.10m .
Earnings released on 30 Mar 2022
EPS came in at $0.37 , while revenue for the quarter reached $779.00m .
FTRE Stock Performance
Access detailed FTRE performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
